DHT drives sebum overproduction and follicular hyperkeratinization in androgen-sensitive skin
Weight loss from GLP-1 medications does not produce a disproportionate reduction in muscle mass or function in either obese mice or humans
GLP-1s may support liver health GLP-1s may benefit people with metabolic dysfunction-associated steatotic liver disease (MASLD), a condition in which excess fat accumulates in the liver
An individual health assessment and possibly genetic testing can help clarify whether treatment aligns with your physiology
Recognizing that each individuals journey is unique, our weight loss solutions take a personalized approach to address your specific needs and goals
The meaning of relative risk is the risk compared to someone not taking the medication 31% is very low and indicates that the risk of developing thyroid cancer due to this medication is relatively low, said Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center